SCHEMBL10861484

SCHEMBL10861484

CC(=O)c1sc(Cl)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
HPGD P15428 4/20 0.40
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DAO P14920 2/20 0.39
DHODH Q02127 2/20 0.39
RAB9A P51151 4/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 1/20 0.38
NPC1 O15118 3/20 0.37
ALOX15 P16050 2/20 0.34
CYP3A4 P08684 1/20 0.34
CHRM1 P11229 1/20 0.34
MAOA P21397 1/20 0.34
TBXA2R P21731 1/20 0.34
ADRA1A P35348 1/20 0.34
HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3425861 0.83 DAO (0.48) MAPTHPGDKDM4EDAORAB9A
SCHEMBL3055848 0.83 DAO (0.39) MAPTHPGDKDM4EL3MBTL1DAO
SCHEMBL5100241 0.80 MAPT (0.40) MAPTHPGDKDM4EL3MBTL1DAO
SCHEMBL26281532 0.78 KMT2A (0.44) MAPTHPGDKDM4EDAORAB9A
SCHEMBL102004 0.77 ALDH1A1 (0.40) MAPTHPGDKDM4EDAODHODH
SCHEMBL26281541 0.75 ALOX15 (0.58) MAPTHPGDKDM4EL3MBTL1DHODH
SCHEMBL5860697 0.74 GSK3B (0.42) MAPTHPGDKDM4EDAODHODH
SCHEMBL14029306 0.74 KDM4E (0.45) MAPTHPGDKDM4EDAODHODH
SCHEMBL26241657 0.74 ALDH1A1 (0.38) MAPTHPGDKDM4EDAODHODH
SCHEMBL14029320 0.74 KDM4E (0.38) MAPTHPGDKDM4EDAODHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118696034-A Novel bicyclic compounds as RAD51 inhibitors 萨提亚疗法股份有限公司 2024-09-24 CN disclosed
US-4590203-A Derivatives of thiophene-2-carboxylic acid and their pharmaceutically acceptable acid or base addition salts and use in treatment of conditions caused by thromboxane A2 LAEVOSAN-GESELLSCHAFT M.B.H. & CO. KG (AT) 1986-05-20 US disclosed